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Abstract
Several lines of evidence suggest that genome-wide association studies (GWAS) have the potential to explain more of the
‘‘missing heritability’’ of common complex phenotypes. However, reliable methods to identify a larger proportion of single
nucleotide polymorphisms (SNPs) that impact disease risk are currently lacking. Here, we use a genetic pleiotropy-informed
conditional false discovery rate (FDR) method on GWAS summary statistics data to identify new loci associated with
schizophrenia (SCZ) and bipolar disorders (BD), two highly heritable disorders with significant missing heritability.
Epidemiological and clinical evidence suggest similar disease characteristics and overlapping genes between SCZ and BD.
Here, we computed conditional Q–Q curves of data from the Psychiatric Genome Consortium (SCZ; n = 9,379 cases and
n= 7,736 controls; BD: n = 6,990 cases and n= 4,820 controls) to show enrichment of SNPs associated with SCZ as a function
of association with BD and vice versa with a corresponding reduction in FDR. Applying the conditional FDR method, we
identified 58 loci associated with SCZ and 35 loci associated with BD below the conditional FDR level of 0.05. Of these, 14
loci were associated with both SCZ and BD (conjunction FDR). Together, these findings show the feasibility of genetic
pleiotropy-informed methods to improve gene discovery in SCZ and BD and indicate overlapping genetic mechanisms
between these two disorders.
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Introduction
Converging evidence suggests that complex human phenotypes
are influenced by numerous genes each explaining a small
proportion of the variance [1]. Though thousands of single
nucleotide polymorphisms (SNPs) have been identified by genome-
wide association studies (GWAS) [2,3], these SNPs fail to explain a
large proportion of the heritability of most complex phenotypes
studied. This is commonly referred to as the ‘missing heritability’
problem. Recent findings indicate that GWAS have the potential
to explain a greater proportion of the heritability of common
complex phenotypes [4–6], and more SNPs are likely to be
identified in larger samples [7]. Due to the polygenic nature of
most complex traits and disorders, a large number of SNPs are
likely to have associations too small in magnitude to be identified
with currently available sample sizes [8]. New analytical methods
are therefore needed to reliably identify a larger proportion of
SNPs associated with complex diseases and phenotypes, since
recruitment and genotyping of sufficiently large samples for
existing methods may be impractical and prohibitively expensive.
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Genetic pleiotropy is defined as a single gene or variant being
associated with more than one distinct phenotype. In the present
study we use a new genetic pleiotropy-informed approach for
GWAS to capture more of the polygenic effects in complex
phenotypes. Given the high number of traits in humans, and the
relatively small number of genes (,20,000), some genes have to
affect multiple traits (genetic pleiotropy) [10]. By combining
independent GWAS from associated disorders, we hypothesize
that for disorders with related etiologies a genetic pleiotropy-
informed approach can significantly improve gene discovery and
help capture more of the missing heritability.
Recent findings suggest overlapping SNPs between several
human traits [9,11] and disorders [12–14]. To date, methods to
assess this genetic pleiotropy have not taken full advantage of the
existing GWAS data and the majority of studies have focused on
the subset of SNPs exceeding a Bonferroni-corrected threshold of
significance for each trait or disorder [12–14]. However, this
approach cannot detect SNPs that only reach genome-wide
significance in the combined analysis but do not meet Bonferroni-
corrected significance in the individual phenotype (hereafter
referred to as polygenic pleiotropy). Combining GWAS statistics
from two disorders also provides increased power to discover genes
associated with common biological mechanisms, and thus inform
on overlapping pathophysiological relationships between the
disorders. In the current study, we use a pleiotropy-informed
statistical approach to improve gene discovery in schizophrenia
and bipolar disorder, two disorders with high heritability [15],
where most of the underlying genetic architecture remains
unknown [13,14], despite recent discoveries [13,14,16,17].
Schizophrenia and bipolar disorder share several clinical
characteristics [18–20], including psychotic symptoms, disorders
of thought and impairment of cognitive functions [21]. The
disorders are often also treated with similar pharmacological
agents [18,19]. Whether schizophrenia and bipolar disorder
should be regarded as separable disease entities or as a single
disease with a spectrum of symptoms [18–20], as proposed in the
continuum hypothesis of psychosis [22], has been much discussed.
With the forthcoming revision of the Diagnostic and Statistical
Manual of Mental Disorders (DSM), this question has received
renewed attention [19,20,23]. Both disorders have an estimated
heritability of 0.7–0.8, and are regarded as complex disorders with
a polygenic architecture. Several lines of evidence have suggested
overlapping genetic susceptibility in bipolar disorder and schizo-
phrenia [15,24–26]. Recently, a combined analysis of two large
GWAS (16,374 cases and 12,044 controls) revealed three loci
(CACNA1C, rs4765905, p=7.061029, ANK3 rs10994359,
p=2.561028, ITIH3/4 region rs2239547, p=7.861029) signifi-
cantly associated with both disorders (Fisher’s combined p in
combined samples) [13,14]. Still, given the high degree of
heritability and large similarities in clinical phenotypes, there are
likely several more undiscovered overlapping genetic factors.
Here, using summary statistics from two independent large
GWAS, we applied a model-free statistical analysis method to
identify SNPs exhibiting pleiotropic relationships between schizo-
phrenia and bipolar disorder. First, we separated out the common
controls in the bipolar disorder and schizophrenia samples [13,14],
ensuring non-overlapping samples. After applying genomic
inflation control, we computed the conditional empirical cumu-
lative distribution functions (cdfs) of the corrected p-values.
Empirical cdfs for schizophrenia SNP p-values were determined
conditional on the significance of the corresponding nominal p-
values in bipolar disorder, and vice versa. For each nominal p-value,
an estimate of the conditional False Discovery Rate (FDR) was
obtained from the conditional empirical cdfs [5]. Using this
conditional FDR method, we constructed two-dimensional FDR
‘‘look-up’’ tables, with FDR in schizophrenia SNPs computed
conditional on nominal bipolar disorder p-values, and vice versa.
Using these tables we identified 58 loci associated with schizo-
phrenia and 35 loci associated with bipolar disorder at a
conditional FDR level of 0.05. We used a conjunction method to
investigate SNPs significantly associated with both schizophrenia
and bipolar disorder. Specifically, we computed the conditional
FDR for schizophrenia given bipolar disorder nominal p-values,
and conditional FDR for bipolar disorder given schizophrenia
nominal p-values, and took the maximum of both values as the
conjunction FDR. With this approach we identified 14 pleiotropic
loci indicating several overlapping genetic risk factors for the two
disorders. Finally, using mixture model-based analyses we
estimated the proportion and distribution of non-null SNPs,
demonstrating that the large increase in power from using
conditional vs. unconditional FDR methods is derived from the
high polygenicity of both phenotypes with many test statistics just
below significance thresholds, and the largely overlapping
distribution (high degree of pleiotropy) of non-null SNPs for
schizophrenia and bipolar disorder.
Results
Q–Q plots of schizophrenia SNPs conditional on
association with bipolar disorder and vice versa
Under large-scale testing paradigms, such as GWAS, quantita-
tive estimates of likely true associations can be estimated from
distributions of summary statistics [27,28]. A common method for
visualizing the ‘enrichment’ of statistical association relative to that
expected under the global null hypothesis is through Q-Q plots of
nominal p-values obtained from GWAS summary statistics. The
usual Q-Q curve has the nominal p-value, denoted by ‘‘p’’, as the
y-ordinate and the corresponding value of the empirical cdf, here
denoted by ‘‘q,’’ as the x-ordinate. Under the global null
hypothesis the theoretical distribution is uniform on the interval
[0,1]. As is common in GWAS, we instead plot 2log10 p against
2log10 q to emphasize tail probabilities of the theoretical and
Author Summary
Genome-wide association studies (GWAS) have thus far
identified only a small fraction of the heritability of
common complex disorders, such as severe mental
disorders. We used a conditional false discovery rate
approach for analysis of GWAS data, exploiting ‘‘genetic
pleiotropy’’ to increase discovery of common gene variants
associated with schizophrenia and bipolar disorders.
Leveraging the increased power from combining GWAS
of two associated phenotypes, we found a striking overlap
in polygenic signals, allowing for the discovery of several
new common gene variants associated with bipolar
disorder and schizophrenia that were not identified in
the original analysis using traditional GWAS methods.
Some of the gene variants have been identified in other
studies with large targeted replication samples, validating
the present findings. Our pleiotropy-informed method
may be of significant importance for detecting effects that
are below the traditional genome-wide significance level
in GWAS, particularly in highly polygenic, complex
phenotypes, such as schizophrenia and bipolar disorder,
where most of the genetic signal is missing (i.e., ‘‘missing
heritability’’). The findings also offer insights into mecha-
nistic relationships between bipolar disorder and schizo-
phrenia pathogenesis.
Polygenic Pleiotropy in Severe Mental Disorders
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empirical distributions. As such, genetic ‘enrichment’ refers to a
leftward shift in the Q-Q curve, corresponding to a larger fraction
of SNPs with nominal 2log10 p-value greater than or equal to a
given threshold. Conditional Q-Q plots are formed by creating
subsets of SNPs based on values of an additional variable (auxiliary
measure) for each SNP, and computing Q-Q plots separately for
each subset of SNPs. If SNP enrichment is captured by variation in
the auxiliary measure, this is expressed as successive leftward
deflections in conditional Q-Q plots as values of the additional
variable increase.
Conditional Q-Q plots for schizophrenia given nominal p-
values of association with bipolar disorder (SCZ|BD; Figure 1A)
show enrichment across different levels of significance for bipolar
disorder. The earlier departure from the null line (leftward shift)
suggests a greater proportion of true associations for a given
nominal schizophrenia p-value. Successive leftward shifts for
decreasing nominal bipolar disorder p-value thresholds indicate
that the proportion of non-null effects in schizophrenia varies
considerably across different levels of association with bipolar
disorder. For example, the proportion of SNPs in the 2log10(pBD)
$3 category reaching a given significance level for schizophrenia
(e.g., 2log10(pSCZ) $4) is roughly 50 times greater than for the
2log10(pBD) $0 category (all SNPs), indicating a high level of
enrichment. An even stronger pleiotropic enrichment can be seen
for bipolar disorder conditioned on nominal p-values of associa-
tion with schizophrenia (BD|SCZ; Figure 1B), Here, the
proportion of SNPs in the 2log10(pSCZ) $3 category reaching a
given significance level for bipolar disorder (e.g.,2log10(pBD)$4) is
roughly 500 times greater than for the 2log10(pSCZ)$0 category
(all SNPs), indicating a very high level of enrichment.
Figure 1. Stratified Q–Q plot and Stratified True Discovery Rate plots. Upper panel: Stratified Q-Q plot of nominal versus empirical2log10 p-
values (corrected for inflation) in A) schizophrenia (SCZ) below the standard GWAS threshold of p,561028 as a function of significance of the
association with bipolar disorder (BD) at the level of 2log10(p).0, 2log10(p).1, 2log10(p).2, 2log10(p).3 corresponding to p,1, p,0.1, p,0.01,
p,0.001, respectively, and in B) BD below the standard GWAS threshold of p,561028 as a function of significance of association with SCZ at the
level of 2log10(p).0, 2log10(p).1, 2log10(p).2, 2log10(p).3 corresponding to p,1, p,0.1, p,0.01, p,0.001, respectively. Dotted lines indicate
the null-hypothesis. Lower panel: Stratified True Discovery Rate (TDR) plots illustrating the increase in TDR associated with increased pleiotropic
enrichment in C) SCZ conditional on nominal BD p-values (SCZ|BD), and D) BD conditional on nominal SCZ p-values (BD|SCZ). For more information
about QQ plots, see Text S1.
doi:10.1371/journal.pgen.1003455.g001
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Conditional True Discovery Rate (TDR) in schizophrenia
is increased by bipolar disorder, and vice versa. Since
categories of SNPs with stronger pleiotropic enrichment are more
likely to be associated with schizophrenia, to maximize power for
discovery all tag SNPs should not be treated exchangeably.
Specifically, variation in enrichment across pleiotropic categories
is expected to be associated with corresponding variation in the
TDR (equivalent to 1-FDR) [29] for association of SNPs with
schizophrenia. A conservative estimate of the TDR for each
nominal p-value is equivalent to 1 – (p/q), easily read off from
conditional Q-Q plots (see Material andMethods). This relationship
is shown for schizophrenia conditioned on nominal bipolar disorder
p-values (SCZ|BD; Figure 1C) and bipolar disorder conditioned on
nominal schizophrenia p-values (BD|SCZ; Figure 1D). For a given
conditional TDR the corresponding estimated nominal p-value
threshold varies with a factor of 100 from the most to the least
enriched SNP category for schizophrenia conditioned on bipolar
disorder (SCZ|BD), and approximately a factor of 500 for bipolar
disorder conditioned on schizophrenia (BD|SCZ).
Schizophrenia gene loci identified with conditional FDR
We constructed a ‘‘conditional’’ Manhattan plot for schizo-
phrenia showing the FDR conditional on bipolar disorder
(Figure 2) and identified significant loci on a total of 18
chromosomes (1–4, 6–16, 18, 20 and 22) associated with
schizophrenia leveraging the reduced FDR obtained by the
associated bipolar disorder phenotype. To estimate the number
of independent loci, we ‘pruned’ the associated SNPs (removed
SNPs with linkage disequilibrium (LD).0.2), and identified a total
of 58 independent loci with a significance threshold of conditional
FDR,0.05 (Table 1). Using the more conservative conditional
FDR threshold of 0.01, 9 independent loci remained significant.
One locus was located in the HLA region on chromosome 6. Of
note, using a standard Bonferroni-corrected approach, no loci
would have been discovered. Using the FDR method in
schizophrenia alone, 4 loci were identified. Of these, the regions
close to TRIM26 (6p21.3), MMP16 (8q21.3) and NT5C2
(10q24.32) have been identified in earlier GWAS studies after
including large replication samples [13]. The remaining loci would
not have been identified in the current sample without using the
pleiotropy-informed conditional FDR method. Of interest, the
VRK2 region (2p16.1) was identified in the previous sample after
including a large schizophrenia replication sample [30], and the
ITIH4 region (3p21.1), ANK3 (10q21) and CACNA1C (12p13.3)
were discovered previously in the same, combined schizophrenia
and bipolar disorder sample [13,14]. Thus, the current pleiotropy-
informed FDR method validated 7 loci discovered in considerably
larger samples, and discovered 51 new loci.
Bipolar disorder gene loci identified with conditional FDR
We constructed a ‘‘conditional’’ Manhattan plot for bipolar
disorder showing the FDR conditional on schizophrenia (Figure 3)
and identified significant loci on a total of 16 chromosomes (1–3,
5–8, 10–14, 16 and 19–22) associated with bipolar disorder
leveraging the reduced FDR obtained by the associated schizo-
phrenia phenotype. To estimate the number of independent loci,
we pruned the associated SNPs (removed SNP with LD.0.2), and
identified a total of 35 independent loci with a significance
threshold of conditional FDR,0.05 (Table 2). Of these, one locus
was complex, i.e. included several significant SNPs, and the rest
were single gene loci. Using the more conservative conditional
FDR threshold of 0.01, 5 independent loci remained significant.
The most significant locus was close to ANK3 on chromosome
(10q21). This is the only locus that would have been discovered
using standard methods based on p-values (Bonferroni correction).
Using the FDR method in bipolar disorder alone, an additional
locus was identified, close to CACNA1C (12p13.3). Both these loci
have been discovered earlier [14,31]. The remaining 33 loci would
not have been identified in the current sample without using the
pleiotropy-informed conditional FDRmethod. Of these, the regions
close to SYNE1 (6q25) and ODZ4 (11q14.1) have been identified in
earlier GWAS after including large replication samples [14,32]. Of
interest, the ITIH3 region (3p21.1), ANK3 (10q21) and CACNA1C
(12p13.3) were discovered previously in the same, combined
schizophrenia and bipolar disorder sample [13,14]. Thus, pleiotro-
py-informed conditional FDR validated 5 loci discovered in
considerably larger samples, and discovered 30 new loci.
Pleiotropic gene loci in both schizophrenia and bipolar
disorder identified with conjunctional FDR
To identify pleiotropic loci in schizophrenia and bipolar
disorder, we performed a conjunction FDR analysis, using this
to construct a ‘‘conjunction’’ Manhattan plot (Figure 4). We
detected 14 independent pleiotropic loci (pruned based on
LD.0.2, black line around large circles) with conjunction
FDR,0.05, all single gene loci, located on a total of 10
chromosomes (chr. 1, 3, 6, 7, 10, 12, 14, 16, 20, 22 – for further
details, please see Table 3). Of these loci, 3 have been implicated
in bipolar disorder and schizophrenia earlier: NOTCH4 (6p21.2)
with schizophrenia using a larger replication sample [13,17], and
the ITIH4 (3p21.1), and CACNA1C (12p13.3) regions, both
discovered previously in the same, combined schizophrenia and
bipolar disorder sample [13,14]. Interestingly only one conjunc-
tional locus was found on chromosome 6, suggesting that there are
several schizophrenia loci on this chromosome not overlapping
with bipolar disorder. The ANK3 locus was not indicated in the
conjunctional analysis, which indicates that the overlap is mostly
driven by the association in bipolar disorder (Table 2). The
direction of the effect (z-scores) across all the pleiotropic SNPs was
the same for bipolar disorder and schizophrenia, except for locus
33 (BC039673, 20p13), which could be due to differences in LD
structure in this region. These findings suggest overlapping genetic
pathways in schizophrenia and bipolar disorders.
Model-based power analyses
Our model-free conditional FDR analyses circumvent the issue
of bias due to model misspecification. However, to ascertain the
impact of effective sample size and conditioning on relative power
over using unconditioned FDR on current sample sizes, it is
necessary to use a model-based approach that estimates the
proportion and distribution of non-null SNPs [33]. We thus posit a
mixture of null and non-null Gaussian distributions [34] (see
Methods and Text S1). Resulting model fits are displayed in
Figure 5 for schizophrenia and bipolar disorder for absolute z
scores $3. Left panels are actual data, whereas right panels are
hypothetical realizations from a doubling of effective sample size,
generated from mixture model fits. Null densities largely coincide
with the overall densities except for z scores with absolute value
larger than 4, at which point the ratio of null to total SNPs, equal
to the local false discovery rate (local FDR), is less than 0.5 (left panels
of Figure 5). Thus, while highly polygenic, most non-null SNPs
have local FDR much larger than 0.05. The local FDR does not
drop below 0.05 until absolute z scores exceed 5. Far more of the
‘‘hidden’’ non-null SNPs lie below this significance threshold than
above it. Many of these hidden SNPs lie just below the significance
threshold, so that an effective doubling of the sample size produces
a ,30 times increase in number of rejected non-null SNPs with
local FDR #0.05 (right panels of Figure 5).
Polygenic Pleiotropy in Severe Mental Disorders
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Another model-based analysis using a bivariate mixture of
Gaussians showed that a very high proportion of the non-null
schizophrenia SNPs are also non-null for bipolar disorder (and vice
versa) leading to large increases in power when using the
conditional FDR approach. This increase in power is also due
to the large number of SNPs with p-values just below the
Bonferroni threshold. Figure 6 shows the power, or sensitivity to
detect non-null SNPs for differing local FDR cut points from
unconditional and conditional local FDR and, for comparison,
from a hypothetical doubling of the number of subjects. Using
conditional over unconditional local FDR results in an increase of
15–20 times the number of non-null SNPs discovered for a local
FDR#0.05. The increase in power for conditional FDR, while
dramatic, is not as large as what would be obtained by doubling
the sample size. This is not unexpected, given that the highly
polygenic non-null SNPs for schizophrenia and bipolar disorder,
many just below the given significance thresholds, are largely but
not completely overlapping. Note, given their highly polygenic
distribution the vast majority of non-null SNPs remain undiscov-
ered even using conditional FDR approaches or under an effective
doubling of the number of subjects.
To test for enrichment with a ‘‘control trait’’ with little or no
polygenic overlap with psychiatric disease, we performed pleiot-
ropy analysis using type 2 diabetes (T2D) GWAS data. The
analyses confirmed that there was a very small level of pleiotropic
enrichment between schizophrenia and T2D, leading to little if
any improvement in statistical power (See Text S1 and Figure S7).
Discussion
In the present study we leveraged the power of GWAS data
from two independent schizophrenia and bipolar disorder
samples, and demonstrate how GWAS from associated psychiatric
disorders can improve discovery of novel susceptibility loci. Using
standard GWAS analytical methods, we identified only one
significant locus. By applying traditional FDR methods in the
separate GWAS samples, we found an additional 6 loci (2 in
bipolar disorder, 4 in schizophrenia). Combining the independent
schizophrenia and bipolar disorder GWAS samples, we identified
a total of 58 loci in schizophrenia and 35 in bipolar disorders, with
conditional FDR,0.05 as a threshold. Nine of the current loci
have been identified earlier in larger samples using standard
GWAS analytical methods (7 in schizophrenia, 5 in bipolar
disorder, and 3 in combined samples), while 10 other loci have
been reported to show borderline association with bipolar disorder
or schizophrenia (Table S1). These results demonstrate the
feasibility of using a cost-effective, pleiotropy-informed conditional
FDR approach to discover common variants in schizophrenia and
bipolar disorders.
The proposed statistical approach is based on the observation
that all SNPs should not be treated as exchangeable. Rather, a
SNP with large effects in two associated phenotypes has a higher
probability of being a true non-null effect, and hence also a higher
probability of being replicated in independent studies. We thus
applied a conditional FDR approach we have previously
developed for GWAS p-values [36], adapted from methods
originally used for linkage analysis and microarray expression
data [5,37]. Decreased conditional FDR (equivalently, increased
conditional TDR) for a given nominal p-value increases power to
detect true non-null effects. Increased conditional TDR is directly
related to increased replication effect sizes and replication rates in
de novo samples. Using this conditional approach we were able to
increase power to detect true non-null signals in independent
studies for given nominal p-values cut-offs. Equivalently, in the
Figure 2. ‘‘Conditional Manhattan plot’’ of conditional 2log10 (FDR) values for schizophrenia (SCZ) alone (black) and SCZ given
bipolar disorder (BD; SCZ|BD, red). SNPs with conditional 2log10 FDR.1.3 (i.e. FDR,0.05) are shown with large points. A black line around the
large points indicates the most significant SNP in each LD block and this SNP was annotated with the closest gene, which is listed above the symbols
in each locus. The figure shows the localization of significant loci. Details about the loci are provided in Table 1.
doi:10.1371/journal.pgen.1003455.g002
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Table 1. Conditional FDR; SCZ loci given BD (SCZ|BD).
Locus SNP neighbor gene chr pval SCZ fdr SCZ fdr SCZ|BD
1 rs2252865 RERE 1p36.23 4.76E-04 0.377 0.030
2 rs11579756 KIAA1026 1p36.21 1.17E-04 0.203 0.037
3 rs4949526 BC042538 1p35.2 1.11E-04 0.181 0.035
4 rs4650608 IFI44 1p31.1 2.06E-04 0.257 0.028
5 rs4907103 LPAR3 1p22.3 9.77E-05 0.181 0.039
6 rs1625579 AK094607 1p21.3 3.76E-06 0.065 0.011
7 rs11205362 PRP3 1q21.1 1.11E-03 0.489 0.033
8 rs10495658 RAD51AP2 2p24.2 .3.99E-05 0.115 0.044
9 rs813592 GCKR 2p23 2.71E-05 0,095 0.014
10 rs10189138 VRK2{ 2p16.1 1.42E-04 0.229 0.038
11 rs11692886 SH3RF3 2q13 1.05E-04 0.181 0.035
12 rs6435387 KIF5C 2q23.1 4.28E-05 0.115 0.020
13 rs17180327 CWC22 2q31.3 1.29E-05 0.080 0.038
14 rs17662626 PCGEM1 2q32 7.79E-05 0.161 0.030
15 rs2675968 C2orf82 2q37.1 5-64E-05 0-143 0-021
16 rs4663627 AGAP1 2q37 1.31E-04 0.203 0.033
17 rs13072940 TRANK1 3p22.2 1.27E-05 0.080 0.013
18 rs4687657 ITIH4{ 3p21.1 1.56E-04 0.229 0.028
19 rs11130874 PTPRG 3p21-p14 9.45E-06 0.077 0.030
20 rs9838229 DKFZp434A128 3q26.33 2.89E-05 0.104 0.045
21 rs13150700 SORBS2 4q35.1 2.77E-04 0.286 0.048
22 rs9379780 SCGN 6p22.3-p22.1 3.78E-06 0.065 0.024
rs198829 HIST1H2BC 6p22.1 2.18E-05 0.088 0.027
23 rs7749823 HIST1H2BD 6p21.3 1.32E-07 0.014 0.005
rs17693963 BC035101 6p22.1 1.87E-07 0.022 0.001
rs13190937 ZSCAN23 6p22.1 1.23E-04 0.203 0.033
rs3130893 ZNF311 6p22.1 3.83E-06 0.065 0.006
rs2523722 TRIM26{ 6p21.32-p22.1 2.54E-07 0.025 0.001
rs2596565 MICA 6p21.33 9.33E-06 0.077 0.009
rs2284178 HCP5 6p21.3 3.31E-04 0.316 0.036
rs805294 LY6G6C 6p21.33 1.11E-04 0.181 0.039
rs9268858 HLA-DRA 6p21.3 1.66E-05 0.084 0.041
rs9268862 HLA-DRA 6p21.3 6.21E-07 0.037 0.002
rs502771 HLA-DRB5 6p21.3 2.97E-05 0.104 0.039
rs9276601 HLA-DQB2 6p21 3.07E-05 0.104 0.015
rs7383287 HLA-DOB 6p21.3 2.71E-05 0.095 0.019
rs1480380 HLA-DMA 6p21.3 1.06E-05 0.077 0.010
24 rs9462875 CUL9 6p21.1 1.61E-04 0.229 0.036
25 rs7787274 FTSJ2 7p22 3.27E-04 0.316 0.028
26 rs12543276 AK055863 8p23.1 1.38E-04 0.203 0.046
27 rs7004633 MMP16{ 8q21.3 1.70E-07 0.018 0.005
28 rs2254884 ABCA1 9q31.1 1.17E-04 0.203 0.032
29 rs6602217 AK094154 10p14 2.29E-05 0.095 0.015
30 rs7084499 ANK3{ 10q21 1.74E-04 0.229 0.040
31 rs2153522 ANK3{ 10q21 7.92E-04 0.449 0.046
32 rs7895695 RRP12 10q24.1 3.57E-05 0.115 0.018
33 rs2298278 SUFU 10q24.32 1.24E-03 0.527 0.037
rs10883817 CNNM2 10q24.32 1.13E-05 0.080 0.020
rs11191580 NT5C2{ 10q24.32 1.71E-06 0.049 0.005
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conditional approach the FDR can be used to control FDR at a
given level while increasing power to discover non-null SNPs over
approaches that treat all SNPs as interchangeable. We also applied
a previously developed conjunction FDR approach [36] to
investigate which SNPs are pleiotropic, impacting risk of both
schizophrenia and bipolar disorder. The conjunction statistic used
is the maximum of the conditional FDR for schizophrenia given
bipolar disorder and vice versa. SNPs that exceed a stringent
conjunction threshold are thus highly likely to be non-null in the
two phenotypes simultaneously.
The extra number of significant loci identified in the current
study compared to ‘conventional’ GWAS methods is remarkable.
The power analyses suggest that the large increase in power is due
to the conditional FDR method, and not an implicit higher false
discovery rate. Compared to conventional GWAS methods,
traditional FDR methods only identified a few extra loci. The
large increase in power came from using conditional FDR, which
identified 14.5 times as many schizophrenia SNPs and 17.5 times
as many bipolar SNPs (at FDR#.05 level) compared to traditional
FDR methods. This large increase in power seems to be due to two
factors: the highly polygenic distribution of non-null SNPs and the
high degree of pleiotropy between schizophrenia and bipolar
disorder. We quantified this using a model-based mixture of null
and non-null Gaussian distributions [34]. Mixture models estimate
roughly 1.2% of tag SNPs are non-null in both bipolar disorder
and schizophrenia. With over 1 million assayed SNPs in common
between both phenotypes, the number of un-pruned, non-null
SNPs is thus in excess of 12,000 in each phenotype. The vast
majority of these non-null SNPs are hidden within the large
proportion (,99%) of null SNPs. Results are in line with recent
findings of a high proportion of variation in schizophrenia
susceptibility captured by common SNPs [6]. Taken together,
these findings strongly suggest that Empirical Bayes methods, as
outlined by Efron [27] should be the method of choice for
analyzing GWAS of polygenic human phenotypes, and for
leveraging pleiotropy with other complex humans traits.
The current findings of polygenic enrichment suggest that
genetic pleiotropy is important in severe mental disorders, as has
been indicated earlier [13–15,24,25]. However, by using condi-
tional FDR, we were able to leverage the overlapping polygenetic
architecture to identify more of the specific SNPs involved. The
current approach identified 58 loci in schizophrenia compared to
7 in the original publication [13]. In bipolar disorder, the added
power from schizophrenia GWAS identified 35 loci compared to
two loci in the original study [14]. It is important to note that this
improvement in gene discovery was obtained despite the much
smaller number of controls in the current analyses because the
original analyses of the two disorders used largely overlapping
Table 1. Cont.
Locus SNP neighbor gene chr pval SCZ fdr SCZ fdr SCZ|BD
34 rs4356203 PIK3C2A 11p15.5-p14 5.48E-05 0.128 0.029
35 rs676318 LRP5 11q13.4 1.41E-05 0.080 0.023
36 rs6591348 GAL 11q13.3 1.16E-05 0.080 0.027
37 rs17126243 LOC399959 11q24.1 1.29E-05 0.080 0.027
38 rs11222395 SNX19 11q25 1.36E-04 0.203 0.032
39 rs7106715 IGSF9B 11q25 6.52E-05 0.143 0.039
40 rs7972947 CACNA1C{ 12p13.3 5.32E-07 0.035 0.013
41 rs1006737 CACNA1C 12p13.3 3.52E-05 0.104 0.022
42 rs4517638 DAOA 13q34 1.10E-05 0.077 0.015
43 rs961196 TTC7B 14q32.11 3.07E-03 0.662 0.044
44 rs1502404 TMCO5A 15q14 1.04E-03 0.489 0.040
45 rs724729 C15orf54 15q14 4.70E-05 0.128 0.038
46 rs1869901 PLCB2 15q15 2.03E-04 0.257 0.039
47 rs2414718 BC033962 15q22.2 4.59E-05 0.128 0.025
48 rs1051168 NMB 15q22 1.27E-04 0.203 0.033
49 rs1078163 NTRK3 15q25 2.67E-05 0.095 0.017
50 rs2304634 DNAJA3 16p13.3 7.90E-05 0.161 0.026
51 rs12708772 SHISA9 16p13.12 3.12E-03 0.662 0.044
52 rs4785714 ZNF276 16q24.3 1.34E-03 0.527 0.034
53 rs12966547 AK093940 18q21.2 6.23E-06 0.071 0.019
54 rs159788 BC039673 20p13 1.23E-03 0.527 0.034
55 rs381523 PPM1F 22q11.22 1.55E-03 0.560 0.038
56 rs9621795 LARGE 22q12.3 1.66E-05 0.084 0.041
57 rs5758209 EP300 22q13.2 5.06E-06 0.068 0.031
58 rs28729663 RPL23AP82 22q13.33 1.82E-04 0.257 0.041
Independent complex or single gene loci (r2,0.2) with SNP(s) with a conditional FDR (condFDR),0.05 in schizophrenia (SCZ) given the association in bipolar disorder
(BD). We defined the most significant SCZ SNP in each LD block based on the minimum condFDR for BD. The most significant SNPs in each LD block are listed. All loci
with SNPs with condFDR,0.05 were used to define the number of the loci. Chromosome location (Chr). SCZ FDR values,0.05 are in bold.
{Same locus identified in previous SCZ genome-wide association studies. All data were first corrected for genomic inflation.
doi:10.1371/journal.pgen.1003455.t001
Polygenic Pleiotropy in Severe Mental Disorders
PLOS Genetics | www.plosgenetics.org 7 April 2013 | Volume 9 | Issue 4 | e1003455
control samples. Since we used data from the 1000 Genomes
Project (1KGP) to calculate LD structure, the number of loci can
vary somewhat compared to the original analysis. For both
disorders, most of the current findings were borderline significant
in the original GWAS mega-analysis, or identified in other GWAS
of partly overlapping samples, such as TRANK1 [38] and SYNE1
[32]. Several of the currently identified genes have been associated
in previous candidate gene studies, such as DAOA [39].
Further, we identified 14 loci strongly associated with both
disorders, compared to three in the original combined analysis
[13,14]. Previous studies have mainly used Fisher combined tests
for joint analysis, which test the null-hypothesis of no association in
any phenotype, which means that the signal can be driven by one
of the phenotypes. In contrast, conjunction FDR analyses assess
the evidence that either phenotype is non-null. It is therefore
difficult to directly compare the current findings with previous
results. However, of the three identified loci in previous combined
analysis [13,14], both the ITIH3-4 and CACNA1C regions were
confirmed with the conjunctional analyses, but not the ANK3
region. We found the latter to be associated with bipolar disorder
in the current analysis, which suggests that previous results found
with Fisher combined statistics were driven by the stronger
association in bipolar disorder [13,14].
The current findings suggest some interesting gene candidates
related to overlapping biology of bipolar disorder and schizophre-
nia. The Major Histocompatibility Complex loci associations with
schizophrenia in previous studies [13,17] seem not to be
strengthened by the combined analysis with bipolar disorder, as
they are minimally represented among the current pleiotropic loci
(conjunction FDR analyses). The only pleiotropic gene on
chromosome 6 was NOTCH 4, which has recently also been
implicated in bipolar disorder [26,40]. The current findings
strengthen the involvement of genes related to calcium homeo-
stasis and receptor functioning. In schizophrenia, both CACNA1C
and ANK3 were identified, and in bipolar disorder TRANK1 and
CACNB2 were also significantly associated. CACNA1C and
CACNB2 are related to key proteins involved in unifying the
generation of calcium spikes in neocortical pyramidal neurons,
which is a closely integrated process [41]. It is likely that such
functional processes could be involved in generation of symptoms
in severe mental disorders, and may thus be a potential therapeutic
target. Interestingly, PPM1F, a Mg2+/Mn2+ dependent protein
phosphatase, related to calcium/calmodulin-dependent protein
kinase II gamma, was also associated with both disorders, and
seems to further strengthen the hypothesis that alterations in
electrophysiological function play a role in the pathophysiology of
these disorders. It is also noteworthy that SNPs located close to
MAD1L1 were significantly associated with both schizophrenia
and bipolar disorder. MAD1L1 is located in a human accelerated
region in the genome, which shows a large difference between
humans and chimpanzees [42], and thus is suggested to be
involved in human-specific traits.
In addition to uncovering more of the missing heritability of
bipolar disorder and schizophrenia, the current findings support
the notion that genetic pleiotropy is important for variation in
human phenotypes [9], and suggest that there is substantial
polygenic pleiotropy between bipolar disorder and schizophrenia
which warrants further exploration. In the current study we
defined pleiotropy as a single gene or variant being associated with
more than one distinct phenotype (diseases) [9]. It is possible that
some of the loci identified in the current study are not pleiotropic
but rather underlie common aspects of the schizophrenia and
Figure 3. ‘‘Conditional Manhattan plot’’ of conditional 2log10 (FDR) values for Bipolar disorder (BD) alone (black) and BD given
schizophrenia (SCZ; BD|SCZ, blue). SNPs with conditional 2log10 FDR.1.3 (i.e. FDR,0.05) are shown with large points. A black line around the
large points indicates the most significant SNP in each LD block and this SNP was annotated with the closest gene, which is listed above the symbols
in each locus. The figure shows the localization of significant loci. Details about the loci are provided in Table 2.
doi:10.1371/journal.pgen.1003455.g003
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bipolar disorder phenotypes [9]. This possibility warrants further
investigation, but requires samples with more detailed information
on clinical characteristics. In the current analyses we focused on
SNPs, but gene-based pleiotropy is also of interest [10], as is the
use of the current approach for developing methods for risk
prediction across traits. However, these applications require raw
data from individual participants and these data are not currently
available.
In conclusion, the current findings demonstrate that in
schizophrenia and bipolar disorder, pleiotropy-informed condi-
tional FDR can improve the statistical power for detecting novel
polygenic effects. Results from conditional and conjunction FDR
analyses also offer insights into potential shared mechanistic
relationships between these two mental disorders.
Materials and Methods
Ethics statement
The relevant institutional review boards or ethics committees
approved the research protocol of the individual GWAS used in
the current analysis and all human participants gave written
informed consent.
Participant samples
We obtained complete GWAS results in the form of summary
statistics p-values from the Psychiatric GWAS Consortium (PGC)
– Schizophrenia and Bipolar Disorder Working Groups. The
schizophrenia (SCZ) GWAS summary statistics results were
obtained from the PGC Schizophrenia Work Group [13], which
consisted of 9,394 cases with schizophrenia or schizoaffective
disorder and 12,462 controls (52% screened) from a total of 17
samples from 11 countries. Semi-structured interviews were used
by trained interviewers to collect clinical information, and
operational criteria were used to establish diagnosis. The quality
of phenotypic data was verified by a systematic review of data
collection methods and procedures at each site, and only studies
that fulfilled these criteria were included. Controls were selected
from the same geographical and ethnic populations as cases. For
further details on sample characteristics and quality control
procedures applied, please see Ripke et al..
The bipolar disorder (BD) GWAS summary statistics results
were obtained from the PGC Bipolar Disorder Working Group
[14], which consisted of n= 16,731 participants, including 7481
cases and 9250 controls, from 11 studies from 7 countries.
Standardized semi-structured interviews were used by trained
interviewers to collect clinical information about lifetime history of
psychiatric illness and operational criteria applied to make lifetime
diagnosis according to recognized classifications. All cases have
experienced pathologically relevant episodes of elevated mood
(mania or hypomania) and meet operational criteria for a BD
diagnosis. The sample consisted of BD I (84%), BD II (11%),
schizoaffective disorder bipolar type (4%), and BD NOS (1%).
Controls were selected from the same geographical and ethnic
populations as cases. For further details on sample characteristics
and quality control procedures applied, please see Sklar et al. [14].
Due to overlapping control samples in these studies, the
common controls were split randomly, and divided between the
two case-control analyses. All results presented here are based on
these non-overlapping control samples, with n= 9379 cases and
n=7736 control samples in schizophrenia, and n= 6990 cases and
n=4820 controls in bipolar disorder analyses.
Statistical analyses
Analyses implemented here were motivated by previously
published stratified FDR methods [5,37]. However, we found
that stratified empirical cdfs exhibited a high degree of variability.
Instead, we computed empirical cdfs for the first phenotype
conditional on nominal p-values of the second being at or below a
given threshold. These conditional empirical cdfs vary more
smoothly as a function of p-value thresholds in the second
(associated) phenotype than do empirical cdfs employing disjoint
strata. Conditional FDR estimates derived from the conditional
Table 2. Conditional FDR; BD loci given SCZ (BD|SCZ).
locus SNP
neighbor
gene Chr pval BD fdr BD
fdr
BD|SCZ
1 rs2252865 RERE 1p36.23 2.19E-04 0.44657 0.01306
2 rs4650608 IFI44 1p31.1 1.00E-03 0.64629 0.04250
3 rs10776799 NGF 1p13.1 9.68E-06 0.17368 0.02579
4 rs7521783 PLEKHO1 1q21.2 5.58E-04 0.57626 0.02503
5 rs573140 SIPA1L2 1q42.2 6.58E-06 0.15946 0.03009
6 rs3911862 FLJ16124 2p14 5.65E-05 0.26909 0.04864
7 rs2271893 LMAN2L 2q11.2 1.85E-05 0.18928 0.00960
8 rs9834970 TRANK1 3p22.2 5.20E-04 0.57626 0.02711
9 rs2535629 ITIH3{ 3p21.1 1.29E-05 0.17896 0.00279
10 rs2902101 ODZ2 5q34 1.04E-04 0.33589 0.03570
11 rs3134942 NOTCH4 6p21.3 1.15E-03 0.66028 0.04844
12 rs9371601 SYNE1{ 6q25 1.10E-06 0.06351 0.02196
13 rs3823198 RPS6KA2 6q27 4.16E-05 0.22281 0.01779
14 rs4332037 MAD1 7p22 3.97E-05 0.22281 0.02918
15 rs6461233 MAD1L1 7p22 5.19E-04 0.57626 0.02711
16 rs10277665 THSD7A 7p21.3 5.42E-05 0.24328 0.01641
17 rs6982836 AX747593 8q13.2 5.64E-05 0.26909 0.04168
18 rs7083127 CACNB2 10p12 1.40E-04 0.37364 0.02191
19 rs10994359 ANK3{ 10q21 8.12E-10 0.00115 0.00001
20 rs10883757 TRIM8 10q24.3 1.11E-03 0.64629 0.03991
21 rs17138230 ODZ4{ 11q14.1 1.43E-05 0.18382 0.03822
22 rs2239037 CACNA1C 12p13.3 9.06E-04 0.64629 0.03928
rs10774037 CACNA1C{ 12p13.3 2.42E-07 0.01859 0.00161
23 rs7296288 DHH 12q13.1 2.88E-05 0.20749 0.02777
24 rs12427050 NEDD1 12q23.1 5.00E-04 0.57626 0.04728
25 rs4390476 SLITRK1 13q31.1 2.03E-04 0.44657 0.03843
26 rs961196 TTC7B 14q32.11 2.96E-04 0.50926 0.01872
27 rs11160562 EML1 14q32 6.93E-04 0.60769 0.03496
28 rs12708772 SHISA9 16p13.12 9.89E-04 0.64629 0.04219
29 rs11863156 AKTIP 16q12.2 7.86E-05 0.30029 0.00865
30 rs1424003 CDH11 16q21 5.54E-05 0.24328 0.01641
31 rs3809646 C16orf7 16q24 5.76E-04 0.60769 0.03171
32 rs281393 RASIP1 19q13.33 5.99E-05 0.26909 0.01293
33 rs159788 BC039673 20p13 6.48E-04 0.60769 0.03080
34 rs3746972 ITGB2 21q22.3 1.42E-04 0.41109 0.04369
35 rs381523 PPM1F 22q11.22 1.28E-03 0.66028 0.04536
For the independent complex or single gene loci (r2,0.2) with SNP(s) with a
conditional FDR (condFDR),0.05 in bipolar disorder (BD) given association with
schizophrenia (SCZ). All independent loci are listed consecutively. Chromosome
location (Chr). All data were first corrected for genomic inflation. BD FDR
values,0.05 are in bold.
{Same locus identified in previous BD genome-wide association studies.
doi:10.1371/journal.pgen.1003455.t002
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Figure 4. ‘‘Conjunction Manhattan plot’’ of conjunction2log10 (FDR) values for schizophrenia (SCZ) and bipolar disorder (BD). SNPs
with 2log10 (FDR).1.3, (i.e. FDR,0.05) for both SCZ and BD are shown with large points. A black line around the large points indicates the most
significant SNP in each LD block and this SNP was annotated with the closest gene, which is listed above the symbols in each chromosome. The
figure shows the localization of the ‘pleiotropic loci’, and further details are provided in Table 3.
doi:10.1371/journal.pgen.1003455.g004
Table 3. Conjunction FDR; pleiotropic loci in SCZ and BD (SCZ&BD).
locus SNP neighbor gene Chr A1 A2 conjfdr BD&SCZ z-score BD z-score SCZ
1 rs2252865 RERE 1p36.23 T C 0.030 3.696 3.494
2 rs4650608 IFI44 1p31.1 T C 0.043 3.289 3.711
4 rs11205362 PRP3 1q21.1 G A 0.033 3.404 3.262
8 rs9834970 TRANK1 3p22.2 C T 0.027 3.470 3.965
9 rs4687657 ITIH4{ 3p21.1 G T 0.028 3.787 3.781
11 rs3134942 NOTCH4{ 6p21.3 G T 0.048 3.251 3.571
15 rs3757440 MAD1L1 7p22 A G 0.031 3.490 3.425
20 rs10883757 TRIM8 10q24.3 C T 0.040 3.261 3.046
22 rs1006737 CACNA1C{ 12p13.3 A G 0.022 4.553 4.137
26 rs961196 TTC7B 14q32.11 C T 0.044 3.618 2.960
28 rs12708772 SHISA9 16p13.12 C T 0.044 3.294 2.955
31 rs1800359 ZNF276 16q24.3 A G 0.035 3.329 3.165
33 rs159788 BC039673 20p13 G A 0.034 3.411 23.232
35 rs381523 PPM1F 22q11.22 A G 0.045 3.220 3.166
Independent complex or single gene loci (r2,0.2) with SNP(s) with a conjunctional FDR (conjFDR),0.05 in schizophrenia (SCZ) and bipolar disorder (BD). All SNPs with a
conjFDR value,0.05 (bidirectional association, i.e. association with SCZ given association with BD (condFDR,0.05) and association with BD given association with SCZ
(condFDR,0.05)) are listed and sorted in each LD block. We defined the most significant SNP in each LD block based on the minimum conjFDR. All independent loci are
listed consecutively, and the same locus number are used as in the condFDR,0.05 results (Table 1). Chromosome (Chr). Z-scores for each pleiotropic locus are provided,
with minor allele (A1) and major allele (A2). All data were first corrected for genomic inflation.
{Same locus identified in previous BD or SCZ genome-wide association studies.
doi:10.1371/journal.pgen.1003455.t003
Polygenic Pleiotropy in Severe Mental Disorders
PLOS Genetics | www.plosgenetics.org 10 April 2013 | Volume 9 | Issue 4 | e1003455
empirical cdfs are a simple extension of Efron’s Empirical Bayes
FDR methods [33].
One advantage of the model-free empirical cdf approach is the
avoidance of bias in conditional FDR estimates from model
misspecification. However, there are inherent limitations to
model-free approaches, especially with respect to inferring
properties of the non-null distribution and, consequently, estimat-
ing power to detect non-null effects. We present complementary
model-based analyses in the Supporting Information that estimate
conditional and conjunctional local false discovery rate (fdr) [27].
Results presented in the Supporting Information using this model-
based fdr corroborate the results of the model-free approaches
presented here.
Genomic control
The empirical null distribution in GWAS is affected by global
variance inflation due to population stratification and cryptic
relatedness [43] and deflation due to over-correction of test
statistics for polygenic traits by standard genomic control methods
[34]. We applied a control method leveraging only intergenic
SNPs which are likely depleted for true associations (Schork et al.,
under review). First, we annotated the SNPs to genic (59UTR, exon,
Figure 5. Histograms of absolute z-scores for bipolar disorder (BD, top panels) and schizophrenia (SCZ, bottom panels) for z-scores
$3. Left panels are actual data, whereas right panels are hypothetical realizations from a doubling of effective sample size, generated from mixture
model fits of f(z) = p0f0(z)+(12p0)f1(z) (see Text S1). Black lines are null sub-densities p0f0(z) and red lines are the full mixture densities f(z). The local
false discovery rate is the ratio fdr = p0f0(z)/f(z). Vertical black bars in each plot indicate the cut-points where local fdr#0.05.
doi:10.1371/journal.pgen.1003455.g005
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intron, 39UTR) and intergenic regions using information from the
1KGP. As illustrated in Figure S1, there is an enrichment of
functional genic regions in schizophrenia compared to the
intergenic SNP category. We used intergenic SNPs because their
relative depletion of associations suggests that they provide a
robust estimate of true null effects and thus seem a better category
for genomic control than all SNPs. We converted all p-values to z-
scores and for each phenotype we estimated the genomic inflation
factor lGC for intergenic SNPs. We computed the inflation factor,
lGC as the median z-score squared divided by the expected
median of a chi-square distribution with one degree of freedom
and divided all test statistics by lGC. The conditional Q-Q plots
for schizophrenia after control for genomic inflation are shown in
Figure S1.
Conditional Q–Q plots for assessing pleiotropic
enrichment
To assess pleiotropic enrichment, we used Q-Q plots condi-
tioned on ‘pleiotropic’ effects. For a given associated phenotype,
enrichment for pleiotropic signals is present if the degree of
deflection from the expected null line is dependent on SNP
Figure 6. ROC curves for bipolar disorder (top) and schizophrenia (bottom). Solid black line show the proportion of non-null SNPs declared
significant (sensitivity) for a given local false discovery rate (1-specificity). The corresponding ROC curves for bipolar disorder local FDR conditional on
schizophrenia (top) and schizophrenia local FDR conditional on bipolar disorder (bottom) are given in red. Power resulting from a hypothetical
doubling of effective subject sample size is given by the dashed black lines.
doi:10.1371/journal.pgen.1003455.g006
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associations with the second phenotype. We constructed
conditional Q-Q plots of empirical quantiles of nominal
2log10(p) values for SNP association with schizophrenia for all
SNPs, and for subsets of SNPs determined by the nominal p-
values of their association with bipolar disorder being at or
below a given threshold. Specifically, we computed the
empirical cumulative distribution of nominal p-values for a
given phenotype for all SNPs and for SNPs with significance
levels below the indicated cut-offs for the other phenotype
(2log10(p)$0, 2log10(p)$1, 2log10(p)$2, 2log10(p)$3 corre-
sponding to p#1, p#0.1, p#0.01, p#0.001, respectively). The
nominal p-values (2log10(p)) are plotted on the y-axis, and the
empirical quantiles (2log10(q), where q = 1- empirical cdf(p)) are
plotted on the x-axis. To assess for polygenic effects below the
standard GWAS significance threshold, we focused the condi-
tional Q-Q plots on SNPs with nominal 2log10(p),7.3
(corresponding to p.561028).
Conditional false discovery rate
Enrichment seen in the conditional Q-Q plots can be directly
interpreted in terms of the FDR. Specifically, for a given p-value
cutoff, the Bayes FDR [33], closely related to the q-value of Storey
[44] is defined as
FDR pð Þ~p0F0 pð Þ=F pð Þ, ð1Þ
where p0 is the proportion of null SNPs, F0 is the null cdf, and F is
the cdf of all SNPs, both null and non-null; see Text S1 for details
on this simple mixture model formulation [33]. Under the null
hypothesis, F0 is the cdf of the uniform distribution on the unit
interval [0,1], so that Eq. [1] reduces to
FDR pð Þ~p0p=F pð Þ, ð2Þ
The cdf F can be estimated by the empirical cdf q =Np/N, where
Np is the number of SNPs with p-values less than or equal to p,
and N is the total number of SNPs. Replacing F by q and
replacing p0 with unity in Eq. [2], we get
FDR pð Þ&p=q, ð3Þ
which is biased upwards as an estimate of Eq. [2] [33]. If p0 is
close to one, as is likely true for most GWAS, the increase in bias
by setting it to unity in Eq. [3] is minimal. The quantity 1 – p/q, is
therefore biased downward, and hence is a conservative estimate
of the TDR=1 - FDR. Note, Eq. [3] is the Empirical Bayes
estimate of the Bayesian FDR described by Efron [33]. Referring
to the formulation of the Q-Q plots, we see that Eq. [3] is
equivalent to the nominal p-value divided by the empirical
quantile, as defined earlier. Given the 2log10 construction of the
Q-Q plots we easily obtain
-log10 FDR pð Þð Þ&log10 qð Þ{log10 pð Þ ð4Þ
demonstrating that the (conservatively) estimated FDR is directly
related to the horizontal shift of the curves in the conditional Q-Q
plots from the expected line x= y, with a larger shift corresponding
to a smaller FDR. This is illustrated in Figure 1. For each p-value
threshold in the associated trait (e.g. bipolar disorder), we
calculated the conditional TDR as a function of p-value in the
primary trait (e.g. schizophrenia, indicated by different colored
curves) in Figure 1 according to Eq. [4].
Conditional statistics—probability of association with
one disorder
We define the conditional FDR as the posterior probability that a
given SNP is null for the first phenotype given that the p-values for
both phenotypes are as small or smaller as the observed p-values.
Formally, this is given by
FDR p1 p2jð Þ~p0 p2ð Þp1=F p1 p2jð Þ, ð5Þ
where p1 is the p-value for the first phenotype, p2 is the p-value for
the second, and F(p1 | p2) is the conditional cdf and p0(p2) the
conditional proportion of null SNPs for the first phenotype given
that p-values for the second phenotype are p2 or smaller. Eq. [5]
makes the assumption, reasonable for independent GWAS, that
summary statistics are independent across phenotypes if they are
null for at least one phenotype. We produce a conservative
estimate of FDR(p1 | p2) by setting p0(p2) = 1 and using the
empirical conditional cdf in place of F(p1 | p2) in Eq. [5]. This is a
straightforward generalization of the Empirical Bayes approach
developed by Efron [33]. We assign a conditional FDR value for
schizophrenia given bipolar disorder p-values (denoted by FDR
SCZ | BD) to each SNP by computing conditional FDR estimates on
a grid and interpolating these estimates into a two-dimensional
look-up table (Figure S2). All SNPs with conditional FDR,0.05
(2log10(FDR).1.3) in schizophrenia given association with
bipolar disorder are listed in Table 1 after ‘pruning’ (removing
all SNPs with r2.0.2 based on 1KGP LD structure). We used the
same procedure, in the opposite direction, to assign a conditional
FDR value (denoted as FDR BD|SCZ) for bipolar disorder given
schizophrenia p-values to each SNP. All SNPs with FDR,0.05
(2log10(FDR).1.3) in bipolar disorder given schizophrenia are
listed in Table 2 after pruning. A significance threshold of
FDR,0.05 nominally corresponds to 5 false positives per 100
reported associations. We present a complementary model-based
approach to estimating conditional FDR in the Text S1.
Conjunction statistics—test of association with both
phenotypes
In order to identify which of the SNPs were associated with
schizophrenia and bipolar disorder we used a conjunction FDR
procedure similar to that described for p-value statistics in Nichols
et al. [45]. This minimizes the effect of a single phenotype driving
the common association signal. Conjunction FDR is defined as the
posterior probability that a given SNP is null for both phenotypes
simultaneously when the p-values for both phenotypes are as small
or smaller than the observed p-values. Formally, conjunction FDR
is given by
FDR p1,p2ð Þ~p0 p1,p2ð ÞF0 p1,p2ð Þ=F p1,p2ð Þ, ð6Þ
where p0(p1, p2) is the proportion of SNPs null for both
phenotypes simultaneously, F0(p1, p2) = p1 p2 is the joint null cdf,
and F(p1, p2) is the joint overall cdf.
Conditional empirical cdfs provide a model-free method to
obtain conservative estimates of Eq. [6]. This can be seen as
follows. Estimate the conjunction FDR by
FDRSCZ&BD~max FDRSCZ BDj ,FDRBD SCZj
  ð7Þ
where FDR SCZ | BD and FDR BD | SCZ (the estimated conditional
FDRs described above) are conservative (upwardly biased)
estimates of Eq. [5]. Thus, Eq. [7] is a conservative estimate of
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max{p1/F(p1 | p2), p2/F(p2 | p1)} =max{p1 F2(p2)/F(p1, p2), p2
F1(p1)/F(p1, p2)}. For enriched samples, p-values will tend to be
smaller than predicted from the uniform distribution, so that
F1(p1)$p1 and F2(p2)$p2. Hence, max{p1 F2(p2)/F(p1, p2), p2
F2(p1)/F(p1, p2)}$max{p1 p2/F(p1, p2), p2 p1/F(p1, p2)} = p1 p2/
F(p1, p2)$p0(p1, p2) p1 p2/F(p1, p2). The last quantity is precisely
the conjunction FDR defined by Eq. [6]. Thus, Eq. [7] is a
conservative model-free estimate of the conjunction FDR. We
present a complementary model-based approach to estimating
conjunction FDR in the Text S1.
We assigned the conjunction FDR values by interpolation into a
bi-directional two-dimensional look-up table (Figure S3). All SNPs
with conjunction FDR,0.05 (2log10(FDR).1.3) with schizophre-
nia and bipolar disorder considered jointly are listed in Table 3
(after pruning), together with the corresponding z-scores and
minor alleles. The z-scores were calculated from the p-values and
the direction of effect was determined by the risk allele.
Conditional Manhattan plots
To illustrate the localization of the genetic markers associated
with schizophrenia given their association with bipolar disorder,
and vice versa, we used a ‘Conditional Manhattan plot’, plotting all
SNPs within an LD block in relation to their chromosomal
location. As illustrated in Figure 2 for schizophrenia, the large
points represent the SNPs with conditional FDR,0.05, whereas
the small points represent the non-significant SNPs. All SNPs
without ‘pruning’ (removing all SNPs with r2.0.2 based on 1KGP
LD structure) are shown. The strongest signal in each LD block is
illustrated with a black line around the circles. This was identified
by ranking all SNPs in increasing order, based on the conditional
FDR value for schizophrenia given bipolar disorder, and then
removing SNPs in LD r2.0.2 with any higher ranked SNP. Thus,
the selected locus was the most significantly associated with
schizophrenia in each LD block (Figure 2). A similar procedure
was used in the conditional Manhattan plot for bipolar disorder
given schizophrenia (Figure 3).
Conjunction Manhattan plots
To illustrate the localization of the pleiotropic genetic markers
associated with both schizophrenia and bipolar disorder, we
present a ‘Conjunction Manhattan plot’, plotting all SNPs with a
significant conjunction FDR within an LD block in relation to
their chromosomal location. As illustrated in Figure 4, the large
points represent the significant SNPs (FDR,0.05), whereas the
small points represent the non-significant SNPs. All SNPs without
‘pruning’ (removing all SNPs with r2.0.2 based on 1KGP LD
structure) are shown, and the strongest signal in each LD block is
illustrated with a black line around the circles. We ranked all SNPs
based on the conjunction statistic and removed SNPs in LD
r2.0.2 with any higher ranked SNP.
Model-based power analyses
While model-free approaches avoid assumptions that may bias
results, it is necessary to take a model-based approach for assessing
the power to detect non-null SNPs [33]. As in Eq. [1], let p0 be the
proportion of null SNPs and let p1 = 12p0 be the proportion of
non-null SNPs. Following Yang et al. [34], the probability density
f(zi) of the test statistic (z score) for the ith SNP is given by
f zið Þ~p0f0 zið Þzp1f1 zið Þ, ð8Þ
where the null density f0(zi) corresponds to a N(0, s0
2) distribution
and the non-null density f1(zi) corresponds to a N(0, s0
2+s12)
distribution. Both s0
2 and s1
2 are estimated from the data (see
Text S1). The local false discovery rate, defined as the posterior
probability that a SNP is non-null given the observed z score, is
given by Efron and Tibshirani [35]
fdr zið Þ~p0f0 zið Þ=f zið Þ: ð9Þ
Using this mixture of Gaussians formulation, we can assess relative
power for gene discovery by determining the proportion of non-
null SNPs with local fdr less than a given cut-off, e.g., 0.05. We can
also determine the impact of scaling the effective sample size on
the distribution f1(zi) of non-null SNPs.
We extend this model to a bivariate framework by postulating a
four groups model of bivariate Gaussians. Let zi be the bivariate z
scores for the ith SNP for schizophrenia and bipolar disorder. The
four groups mixture model is given by
f zið Þ~p0f0 zið Þzp1f1 zið Þzp2f2 zið Þzp3f3 zið Þ, ð10Þ
where p0 is the proportion of SNPs which are null for both
phenotypes, p1 and p2 are the proportion of SNPs which are non-
null for schizophrenia and null for bipolar disorder (and vice versa),
and p3 is the proportion of SNPs non-null for both simultaneously.
The component densities f0, f1, f2, and f3 are bivariate Gaussian with
zero mean and variance-covariance matrices estimated from the
data. From model [9], we can compute conditional local fdr, similar
to the conditional FDR described above. We can also determine the
degree of pleiotropy from the estimated value of p3. Details of the
methods for mixture models, local false discovery rate, and estimates
of polygenicity, the degree of pleiotropic overlap, and power are
presented in Text S1 and Figures S4, S5, S6, S7.
Supporting Information
Figure S1 Stratified Q-Q plots of nominal versus empirical -
log10 p-values of genic vs. intergenic regions, controlling for
genomic inflation in schizophrenia (p,561028). The plots
illustrate the enrichment of genic SNPs compared to all SNPs,
and lack of enrichment for intergenic SNPs. The plot in top panel is
based on uncorrected data, showing inflation (l 1.24). The
intergenic SNPs were used for genomic control. The plot in bottom
panel is based on data after correcting for inflation.
(DOC)
Figure S2 Based on the combination of p-value for the SNP in
schizophrenia (SCZ) and bipolar disorder (BD), we assigned a
conditional FDR value for SCZ to each SNP, by interpolation into
a 2-dimensional lookup table. This is shown in upper panel for SCZ
conditioned on BD, denoted FDRSCZ | BD. BD conditioned on
SCZ, denoted FDRBD|SCZ is shown in lower panel. Color scale
refers to FDR values.
(DOC)
Figure S3 Based on the combination of p-value for the SNP in
schizophrenia (SCZ) given bipolar disorder (BD), and the
combination of p-value for the SNP in BD given SCZ, we
assigned a conjunction FDR value for SCZ and BD to each SNP,
by interpolation into a bi-directional 2-D look up table. This is
denoted FDRBD&SCZ. Color scale refers to FDR values.
(DOC)
Figure S4 QQ-plot for schizophrenia (SCZ). Dotted lines give
marginal fit based on MCMC estimates for the two-groups
mixture model. Dashed line gives null distribution.
(DOC)
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Figure S5 QQ-plot for bipolar disorder (BD). Dotted lines give
marginal fit based on MCMC estimates for the two-groups
mixture model. Dashed line gives null distribution.
(DOC)
Figure S6 QQ-plot for type 2 diabetes (T2D). Dotted lines give
marginal fit based on MCMC estimates for the two-groups
mixture model. Dashed line gives null distribution.
(DOC)
Figure S7 ROC curves for schizophrenia. Solid black line shows
the proportion of non-null SNPs declared significant (Power;
Sensitivity) for a given local false discovery rate (Local fdr; 1-
specificity). The corresponding ROC curve for schizophrenia
(SCZ) local false discovery rate conditional on type 2 diabetes
(T2D) is given in red (SCZ | T2D). Red and black lines are nearly
overlapping due to almost no increase in power. Power resulting
from a hypothetical doubling of effective subject sample size is
given by the dashed black line.
(DOC)
Table S1 Associated loci and previous GWAS findings.
(DOC)
Text S1 Supporting statistical methods.
(DOC)
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